Related references
Note: Only part of the references are listed.Ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections
Mohamad-Ali Trad et al.
JOURNAL OF CHEMOTHERAPY (2017)
β-Lactamase Characterization of Gram-Negative Pathogens Recovered from Patients Enrolled in the Phase 2 Trials for Ceftazidime-Avibactam: Clinical Efficacies Analyzed against Subsets of Molecularly Characterized Isolates
Rodrigo E. Mendes et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Activity of Fosfomycin against Extended-Spectrum-β-Lactamase-Producing Uropathogens in Patients in the Community and Hospitalized Patients
Katherine Linsenmeyer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
Jessica B. Cprek et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Increasing Incidence of Extended-Spectrum -Lactamase-Producing Escherichia coli in Community Hospitals throughout the Southeastern United States
Joshua T. Thaden et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2016)
Fluoroquinolone and Third-Generation-Cephalosporin Resistance among Hospitalized Patients with Urinary Tract Infections Due to Escherichia coli: Do Rates Vary by Hospital Characteristics and Geographic Region?
Monique R. Bidell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Antimicrobial Activities of Ceftazidime-Avibactam and Comparator Agents against Gram-Negative Organisms Isolated from Patients with Urinary Tract Infections in US Medical Centers, 2012 to 2014
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Changes in the Frequencies of β-Lactamase Genes among Enterobacteriaceae Isolates in US Hospitals, 2012 to 2014: Activity of Ceftazidime-Avibactam Tested against β-Lactamase-Producing Isolates
Mariana Castanheira et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
Deanna J. Buehrle et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Antibiotic Resistance among Urinary Isolates from Female Outpatients in the United States in 2003 and 2012
Guillermo V. Sanchez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
In Vitro Susceptibility to Ceftazidime-Avibactam of Carbapenem-Nonsusceptible Enterobacteriaceae Isolates Collected during the INFORM Global Surveillance Study (2012 to 2014)
Boudewijn L. M. de Jonge et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Susceptibility of Multidrug-Resistant Gram-Negative Urine Isolates to Oral Antibiotics
Elizabeth B. Hirsch et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Use of antimicrobial resistance information and prescribing guidance for management of urinary tract infections: survey of general practitioners in the West Midlands
Dean Ironmonger et al.
BMC INFECTIOUS DISEASES (2016)
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
Tamar F. Barlam et al.
CLINICAL INFECTIOUS DISEASES (2016)
Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections
C. Hauck et al.
CLINICAL MICROBIOLOGY AND INFECTION (2016)
Global epidemiology of urinary tract infections
Zafer Tandogdu et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2016)
Susceptibility of contemporary isolates to fosfomycin: a systematic review of the literature
Konstantinos Z. Vardakas et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Comparison of fosfomycin to ertapenem for outpatient or step-down therapy of extended-spectrum β-lactamase urinary tract infections
Michael P. Veve et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2016)
Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial
Jennifer A. Huntington et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study
Yehuda Carmeli et al.
LANCET INFECTIOUS DISEASES (2016)
Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study
Yi-Yun Liu et al.
LANCET INFECTIOUS DISEASES (2016)
Efficacy of Humanized High-Dose Meropenem, Cefepime, and Levofloxacin against Enterobacteriaceae Isolates Producing Verona Integron-Encoded Metallo-β-Lactamase (VIM) in a Murine Thigh Infection Model
Islam M. Ghazi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Two Simple Rules for Improving the Accuracy of Empiric Treatment of Multidrug-Resistant Urinary Tract Infections
Katherine Linsenmeyer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Eravacycline (TP-434) Is Efficacious in Animal Models of Infection
Trudy H. Grossman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates
Nan-Yao Lee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Clinical Appraisal of Fosfomycin in the Era of Antimicrobial Resistance
Sangeeta Sastry et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Ceftazidime-Avibactam Activity against Multidrug-Resistant Pseudomonas aeruginosa Isolated in US Medical Centers in 2012 and 2013
Helio S. Sader et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Multicenter Retrospective Study of Cefmetazole and Flomoxef for Treatment of Extended-Spectrum-β-Lactamase-Producing Escherichia coli Bacteremia
Yasufumi Matsumura et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Ciprofloxacin resistance in community- and hospital-acquired Escherichia coli urinary tract infections: a systematic review and meta-analysis of observational studies
Oyebola Fasugba et al.
BMC INFECTIOUS DISEASES (2015)
Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone
Tony Antoniou et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2015)
Kidney function and the use of nitrofurantoin to treat urinary tract infections in older women
Namisha Singh et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2015)
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Zubair A. Qureshi et al.
CLINICAL INFECTIOUS DISEASES (2015)
Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) infections: are carbapenem alternatives achievable in daily practice?
B. Pilmis et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2015)
Epidemiology of Carbapenem-Resistant Enterobacteriaceae in 7 US Communities, 2012-2013
Alice Y. Guh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Nitrofurantoin revisited: a systematic review and meta-analysis of controlled trials
Angela Huttner et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Overdiagnosis of Urinary Tract Infection and Underdiagnosis of Sexually Transmitted Infection in Adult Women Presenting to an Emergency Department
Myreen E. Tomas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Risk factors of community-onset urinary tract infections caused by plasmid-mediated AmpC β-lactamase-producing Enterobacteriaceae
Chi-Hung Lee et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2015)
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)
Florian M. Wagenlehner et al.
LANCET (2015)
Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus
Roger L. Nation et al.
LANCET INFECTIOUS DISEASES (2015)
Impact of a Stewardship-Initiated Restriction on Empirical Use of Ciprofloxacin on Nonsusceptibility of Escherichia coli Urinary Isolates to Ciprofloxacin
Kristen A. O'Brien et al.
PHARMACOTHERAPY (2015)
Urinalysis Orders Among Patients Admitted to the General Medicine Service
Penny Yin et al.
JAMA INTERNAL MEDICINE (2015)
Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: A 7-year surveillance study
Antonio Sorlozano et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2014)
In Vitro Activity of Fosfomycin against Escherichia coli Isolated from Patients with Urinary Tract Infections in Canada as Part of the CANWARD Surveillance Study
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence
Matthew E. Falagas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Appropriate Antibiotic Use for Patients With Urinary Tract Infections Reduces Length of Hospital Stay
Veroniek Spoorenberg et al.
CLINICAL INFECTIOUS DISEASES (2014)
Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance
D. van Duin et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Colistin bladder instillation, an alternative way of treating multi-resistant Acinetobacter urinary tract infection: a case series and review of literature
R. Giua et al.
INFECTION (2014)
Urinary Tract Infection Syndromes Occurrence, Recurrence, Bacteriology, Risk Factors, and Disease Burden
Betsy Foxman
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2014)
Efficacy of empirical therapy with non-carbapenems for urinary tract infections with extended-spectrum beta-lactamase-producing Enterobacteriaceae
Takanori Asakura et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2014)
Tigecycline in treatment of multidrug-resistant Gram-negative bacillus urinary tract infections: a systematic review
K. Brust et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients
G. V. Sanchez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012)
Robert K. Flamm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Clinical and bacteriological efficacy of amikacin in the treatment of lower urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae
Tumay Ipekci et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2014)
Multistate Point- Prevalence Survey of Health Care- Associated Infections
Shelley S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Recommendations for the Empirical Treatment of Complicated Urinary Tract Infections Using Surveillance Data on Antimicrobial Resistance in the Netherlands
Maike Koningstein et al.
PLOS ONE (2014)
Clinical comparison of ertapenem and cefepime for treatment of infections caused by AmpC beta-lactamase-producing Enterobacteriaceae
Lisa M. Blanchette et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2014)
Healthcare-associated urinary tract infections in hospitalized urological patients-a global perspective: results from the GPIU studies 2003-2010
Mete Cek et al.
WORLD JOURNAL OF UROLOGY (2014)
Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study
Michael Fralick et al.
BMJ-BRITISH MEDICAL JOURNAL (2014)
Nitrofurantoin Contraindication in Patients with a Creatinine Clearance Below 60 mL/min: Looking for the Evidence
Mandy Oplinger et al.
ANNALS OF PHARMACOTHERAPY (2013)
New β-lactam-β-lactamase inhibitor combinations in clinical development
David M. Shlaes
ANTIMICROBIAL THERAPEUTICS REVIEWS: THE BACTERIAL CELL WALL AS AN ANTIMICROBIAL TARGET (2013)
Correlations of Antibiotic Use and Carbapenem Resistance in Enterobacteriaceae
Milena McLaughlin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Women with symptoms of uncomplicated urinary tract infection are often willing to delay antibiotic treatment: a prospective cohort study
Bart J. Knottnerus et al.
BMC FAMILY PRACTICE (2013)
Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009)
Ines Linhares et al.
BMC INFECTIOUS DISEASES (2013)
Cefepime Therapy for Monomicrobial Bacteremia Caused by Cefepime-Susceptible Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae: MIC Matters
Nan-Yao Lee et al.
CLINICAL INFECTIOUS DISEASES (2013)
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)
Ellen Jo Baron et al.
CLINICAL INFECTIOUS DISEASES (2013)
The Use of Cefepime for Treating AmpC β-Lactamase-Producing Enterobacteriaceae
Pranita D. Tamma et al.
CLINICAL INFECTIOUS DISEASES (2013)
Antimicrobial Susceptibility of Inpatient Urinary Tract Isolates of Gram-Negative Bacilli in the United States: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) Program: 2009-2011
Sam K. Bouchillon et al.
CLINICAL THERAPEUTICS (2013)
Activities of carbapenem and comparator agents against contemporary US Pseudomonas aeruginosa isolates from the CAPITAL surveillance program
Brian J. Morrow et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Ceftazidime-Avibactam: a Novel Cephalosporin/beta-lactamase Inhibitor Combination
George G. Zhanel et al.
DRUGS (2013)
Ineffectiveness and adverse events of nitrofurantoin in women with urinary tract infection and renal impairment in primary care
Arjen F. J. Geerts et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study
S. Shilo et al.
INFECTION (2013)
Antimicrobial-Resistant Pathogens Associated with Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
Dawn M. Sievert et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2013)
Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak
Jose Ramon Pano-Pardo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Activity of biapenem (RPX2003) combined with the boronate -lactamase inhibitor RPX7009 against carbapenem-resistant Enterobacteriaceae
David M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11
Andrew J. Denisuik et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2013)
Alternatives to carbapenems in ESBL-producing Escherichia coli infections
D. Fournier et al.
MEDECINE ET MALADIES INFECTIEUSES (2013)
Treatment of extensively drug-resistant Gram-negative infections in critically ill patients: Outcome of a consensus meeting at the 13th Asia-Pacific Congress of Clinical Microbiology and Infection, October 2012
Paul Anantharajah Tambyah et al.
JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE (2013)
Molecular Epidemiological Analysis of Escherichia coli Sequence Type ST131 (O25:H4) and blaCTX-M-15 among Extended-Spectrum-β- Lactamase-Producing E. coli from the United States, 2000 to 2009
James R. Johnson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Evaluation of Clinical Outcomes in Patients with Bloodstream Infections Due to Gram-Negative Bacteria According to Carbapenem MIC Stratification
John S. Esterly et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Impact of Cefepime Therapy on Mortality among Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae and Escherichia coli
Teena Chopra et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
Jesus Rodriguez-Bano et al.
CLINICAL INFECTIOUS DISEASES (2012)
Both Host and Pathogen Factors Predispose to Escherichia coli Urinary-Source Bacteremia in Hospitalized Patients
Jonas Marschall et al.
CLINICAL INFECTIOUS DISEASES (2012)
Excess Deaths Associated With Tigecycline After Approval Based on Noninferiority Trials
Paritosh Prasad et al.
CLINICAL INFECTIOUS DISEASES (2012)
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
R. Canton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study
Jose A. Vazquez et al.
CURRENT MEDICAL RESEARCH AND OPINION (2012)
Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study 2009-2010
Daryl J. Hoban et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2012)
Nitrofurantoin in the treatment of extended-spectrum β-lactamase-producing Escherichia coli-related lower urinary tract infection
Meltem Isikgoz Tasbakan et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2012)
Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteria
L. S. Briongos-Figuero et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2012)
Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum -lactamases: a systematic review and meta-analysis
Konstantinos Z. Vardakas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2012)
Piperacillin-tazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae
Cheol-In Kang et al.
JOURNAL OF INFECTION (2012)
Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER
Jae Hoon Lee et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
New definitions of extended-spectrum ß-lactamase conferring worldwide emerging antibiotic resistance
Jung Hun Lee et al.
MEDICINAL RESEARCH REVIEWS (2012)
Efficacy of Pivmecillinam for Treatment of Lower Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae
Emilia Titelman et al.
MICROBIAL DRUG RESISTANCE (2012)
Virulence Profiles of Bacteremic Extended-Spectrum β-Lactamase-Producing Escherichia coli: Association with Epidemiological and Clinical Features
Jesus Rodriguez-Bano et al.
PLOS ONE (2012)
Antimicrobial Resistance in Urinary Tract Pathogens in Canada from 2007 to 2009: CANWARD Surveillance Study
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
Kalpana Gupta et al.
CLINICAL INFECTIOUS DISEASES (2011)
Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy
S. Meier et al.
INFECTION (2011)
Critical review of current definitions of urinary tract infections and proposal of an EAU/ESIU classification system
Truls E. Bjerklund Johansen et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
David M. Livermore et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2011)
Risk factors for fluoroquinolone-resistant Escherichia coli in adults with community-onset febrile urinary tract infection
Willize E. van der Starre et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Trends in carbapenemase-producing Escherichia coli and Klebsiella spp. from Europe and the Americas: report from the SENTRY antimicrobial surveillance programme (2007-09)
Mariana Castanheira et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Impact of discordant empirical therapy on outcome of community-acquired bacteremic acute pyelonephritis
Seung Soon Lee et al.
JOURNAL OF INFECTION (2011)
Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in teaching hospital in Taiwan
Hsin-Yi Liu et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2011)
Risk factors and outcomes of carbapenem-nonsusceptible Escherichia coli bacteremia: A matched case-control study
Hong-Jyun Chang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2011)
Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
Simon Auer et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
High Prevalence of ST131 Isolates Producing CTX-M-15 and CTX-M-14 among Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates from Canada
Gisele Peirano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
Thomas M. Hooton et al.
CLINICAL INFECTIOUS DISEASES (2010)
Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation
A. Michalopoulos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum β-lactamase (ESBL)-producing Escherichia coli
Jesus Oteo et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials
Matthew E. Falagas et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Carbapenem Versus Fosfomycin Tromethanol in the Treatment of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli-Related Complicated Lower Urinary Tract Infection
S. Senol et al.
JOURNAL OF CHEMOTHERAPY (2010)
Risk factors for fluoroquinolone resistance in Gram-negative bacilli causing healthcare-acquired urinary tract infections
P. Rattanaumpawan et al.
JOURNAL OF HOSPITAL INFECTION (2010)
Impact of Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae on the Outcome of Community-onset Bacteremic Urinary Tract Infections
Ya-Sung Yang et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2010)
The epidemiology of urinary tract infection
Betsy Foxman
NATURE REVIEWS UROLOGY (2010)
Effectiveness of five different approaches in management of urinary tract infection: randomised controlled trial
P. Little et al.
BRITISH MEDICAL JOURNAL (2010)
Nursing homes as a reservoir of extended-spectrum β-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli
Paul J. Rooney et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Identification and pretherapy susceptibility of pathogens' in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the united states from November 2004 through April 2006
Janet Peterson et al.
CLINICAL THERAPEUTICS (2007)
Efficacy and safety of aminoglycoside monotherapy: systematic review and meta-analysis of randomized controlled trials
Liat Vidal et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: The LUTIW project
Sven A. Ferry et al.
SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE (2007)
One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study
Paramananthan Mariappan et al.
BJU INTERNATIONAL (2006)
Effect of aminoglycoside and β-lactam combination therapy versus β-lactam monotherapy on the emergence of antimicrobial resistance:: A meta-analysis of randomized, controlled trials
IA Bliziotis et al.
CLINICAL INFECTIOUS DISEASES (2005)
Intensive care unit-acquired urinary tract infections in a regional critical care system
KB Laupland et al.
CRITICAL CARE (2005)
Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women - A randomized trial
TM Hooton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Does this woman have an acute uncomplicated urinary tract infection?
S Bent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Share Paper
